New stent aims to keep heart arteries open longer
NCT ID NCT06071702
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early study tests a new stent that releases a drug to prevent artery re-narrowing in 30 people with coronary artery disease. The stent is placed during a routine procedure to prop open blocked heart vessels. Researchers will check if the artery stays open after 13 months and track any heart-related events.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ridaforolimus
- What this could lead to
- If successful, this stent could offer a new option to keep coronary arteries open and reduce the need for repeat procedures in people with heart disease.
- What could go wrong
- This is a very early, small study (30 people) that is currently suspended. The stent may not work as intended or could cause complications like blood clots or heart attacks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St Francis Hospital Heart Center
Roslyn, New York, 11576, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?